To Compare Induction characteristics of two different Anaesthetic drugs-Etomidate Lippuro and Propofol

Comparison of Induction characteristics of two Anaesthetic agents-Etomidate Lippuro and Propofol

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/09/009613

Enrollment

100

Registered

2017-09-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA1 and ASAII patients with 8 to 12 weeks of amenorrhoea

Interventions

Intervention1: Injection Etomidate Lippuro 0.3 mg/kg body weight: Single dose of Injection Etomidate Lippuro 0.3 mg/kg body weight injected over a period of 40 seconds. Control Intervention1: Injectio

Eligibility

Inclusion criteria

Inclusion criteria: ASAi and II patients of the above age group posted for Elective Medical Termination of Pregnancy (MTP)

Exclusion criteria

Exclusion criteria: 1 Haemo-dynamically unstable patients 2 Patiens withAllergy to egg protein 3 Patients with primary or secondary dysfunction of adrenal gland 4 Patients with epilepsy

Design outcomes

Primary

Measure	Time frame
To compare the heamodynamic parameters and onset times of two drugsTimepoint: At induction and then every 2 minutes till the end of the surgery	—

Secondary

Measure	Time frame
incidence of side effects of the drugs in the form of 1 pain on injection 2 myoclonus 3 Nausea vomiting and 4 thrombophlebitisTimepoint: 1 2- At the time of inection 3 Immediately postoperatively 4 24 hours postoperatively	—

Countries

India

Contacts

Public ContactDr Ajay Pal

Lokmanya Tilak Municipal and General Hospital

drbasantwani@hotmail.com9819018461

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026